药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201233018140620.pdf,201233018135722.PDF,201233018135336.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文拜唐苹处方资料(仅供参考)
拜唐苹®Glucobay 中文别名:阿卡波糖、阿卡波糖,拜糖平
英文别名:Acarbose
生产企业:德国拜耳
药品类别:胰腺激素及其它影响血糖药 性 状 为一种新型口服降糖药。
药理药动 本品是一个α-糖苷酶抑制剂。它结合于碳水化合物分解酶(α-糖苷酶),从而竞争性和可逆性地抑制了小肠中碳水化合物的分解,使糖的吸收相应减缓,因而拜糖平可以减少饭后血糖浓度的增高。由于小肠内糖吸收的减缓和大肠内糖的调节吸收,使一天内血糖浓度平稳,平均值下降。拜糖平对非胰岛素依赖型糖尿病人单独治疗有明显疗效,可降餐后血糖和空腹血糖。它也适合与其它日服胶降糖药合用,临床试验1年结果,拜糖平对55%已服磺脲类药物的病人和的%已服双胍类药物的病人,均有明显的作用。
适 应 症 非胰岛素依赖型糖尿病人,当单纯饮食治疗不能控制血糖时,拜糖平应用作一线治疗药。 当现有常规降糖药不能正常控制代谢状态时,拜糖平可加入合并使用。 胰岛素依赖型糖尿病人可配合胰岛素合并使用。 用法用量 每片50mg,初起量为1天3次每次一片,以后可增加到一天3次每次2片。
不良反应 因糖类在小肠内分解及吸收缓慢,停留时间延长,经肠道细菌的酵解而产气增多,因此可引起腹胀、腹痛及腹泻等。 也可引起低血糖。 禁忌症 禁用于对阿卡波糖的过敏反应者; 也不能用于18岁以下的病人; 有明显消化、吸收障碍的慢性肠功能紊乱; 禁用于肠胀气面可能恶化的情况(如严重的疝气、肠梗阻和肠溃疡等)。
孕妇及哺乳期妇女用药 怀孕期间禁服拜糖平,哺乳期也不要服用拜糖平。
Brand Name Glucobay
Common Name acarbose
DIN (Drug Identification Number) 02190893 GLUCOBAY 100MG TABLET 02190885 GLUCOBAY 50MG TABLET
How does this medication work? What will it do for me? Acarbose is an antidiabetic medication known as an α-glucosidase inhibitor. Acarbose is used to control blood glucose for people with type 2 diabetes when diet, exercise, and weight reduction have not controlled it well enough on their own.
This medication is often added to other diabetes medications when additional blood glucose control is needed. Acarbose works by preventing the breakdown of starch into sugar (by blocking the α-glucosidase enzyme) and helps to lower blood sugar levels after meals.
Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.
Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.
How should I use this medication? The recommended adult dose of acarbose varies. The starting dose is 50 mg once daily, with a gradual increase in dose as needed to control blood glucose. The maximum daily dose is 100 mg three times daily, taken with the first bite of a meal.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
Take this medication regularly in order to keep blood glucose under control. If you forget a dose, start your regular dosing schedule again with your next meal. Do not take a double dose to make up for a missed one. Do not stop taking this medication without first consulting your doctor.
Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
What form(s) does this medication come in? 50 mg Each round, off-white, scored tablet, marked with "G50" on one side and the Bayer cross on the other, contains acarbose 50 mg. Nonmedicinal ingredients: cornstarch, magnesium stearate, microcrystalline cellulose, and silicon dioxide. Preservative- and dye-free.
100 mg Each round, off-white, scored tablet, marked with "G100" on one side and the Bayer cross on the other, contains acarbose 100 mg. Nonmedicinal ingredients: cornstarch, magnesium stearate, microcrystalline cellulose, and silicon dioxide. Preservative- and dye-free.
Who should NOT take this medication? Do not take this medication if you: are allergic to acarbose or any ingredients of the medication have a condition that may worsen as a result of increased gas formation in the intestine (e.g., larger hernias) have a predisposition to intestinal blockage have chronic intestinal conditions associated with severe problems with digestion or absorption have colonic ulceration have diabetic ketoacidosis have inflammatory bowel disease have partial intestinal blockage
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201233018140620.pdf,201233018135722.PDF,201233018135336.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- |